CDER chief touts AI potential to reduce quality defects, encourages adoption of AI tools
Regulatory NewsJoanne S. Eglovitch.jpg?lang=en-us&ext=.jpg)
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy